As the publishing industry evolves, inkjet printing is touted as a leading technology, driving innovation and efficiency.

Jans and colleagues report compelling insights relevant to these questions by looking at how bacterial binding to cells lining ... this compound blocked the adhesive and genotoxic activity of ...

The long-awaited multiplayer update to legendary roguelike The Binding of Isaac is now less than two weeks away, and the game's developer is celebrating with an additional balance pass - albeit ...

Do you love both books and flowers and want to display them in your home? Check out how to turn a Dollar Tree book and some floral stems into a decorative item.

He takes a job in a mysterious library – allowing Murakami to explore the power of books, along with his favourite themes of love and loss, with typical storytelling prowess. One of the Soviet ...

A record number of books were banned in districts across the country during the 2023-2024 school year, according to a free speech organization. By Alexandra Alter Jodi Picoult’s “Nineteen ...

In fact, autumn is the time to double down on reading—cold days and long nights are the peak conditions for curling up with a book. Fall is the busiest, buzziest season in book publishing ...

Interconnects are the glue, according to Rob Dimond, system architect and fellow at Arm. They encompass the network on chip (NoC), which is on the chiplet, all the other interconnects that reside ...

Plans for a biography were stalled, then cut short, when Zehme, the author of books about Frank Sinatra and Andy Kaufman, died in 2023. Finished by his former research assistant, “Carson the ...

On October 8, the Nobel Prize in Physics was awarded to Professors Geoffrey E. Hinton and John J. Hopfield in recognition of their contributions to the field of artificial intelligence. A few ...

This Halloween, it’s all about bold beauty that marries glamour with a spooky twist. Whether you’re going full gothic chic or experimenting with crystals and glitter, these looks will have you casting ...

Novartis will apply Monte Rosa Therapeutics’ target discovery platform to develop its T and B cell-modulating molecular glue degraders targeting the VAV1 protein—starting with its Phase I ...